Global HbA1c Testing Market – Industry Trends and Forecast to 2030

HbA1c Testing Market Analysis and Size

The rise in the number of research organizations and associations for diabetes is among the important factor expected to intensify the growth and demand of the HbA1c testing market. In addition, the increase in the initiatives by key players and the rise in the prevalence of diabetes is also expected to contribute to the growth in the market. Also, the rapid rise in medical tourism and the increase in the demand for accurate measurement of HbA1c levels are likely to enhance the market's growth. Furthermore, the increase in geriatric population and influence of sedentary lifestyle and unhealthy diet are also one of the significant factors expected to fuel the development of the market.

Data Bridge Market Research analyses that the market, which was USD 1,826.76 Million in 2022, would rocket up to USD 3,270.83 Million by 2030 and is expected to undergo a CAGR of 11.62% during the forecast period. “Kits” dominates the product type segment of the market owing to the increasing awareness among individuals and healthcare providers about the importance of glycaemic control in managing diabetes. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

HbA1c Testing Market Scope and Segmentation

Market Definition

Hemoglobin A1C (HbA1c) is a type of hemoglobin bound to glucose. The HbA1c test helps provide the patient with the average blood sugar level only for the past two to three months. These tests are generally combined with other tests for the better results.

HbA1c Testing Market Dynamics

Drivers

• Increasing prevalence of diabetes

The rising prevalence of diabetes is a significant driver for the market. HbA1c tests are widely used for monitoring and diagnosing diabetes, driving the demand for HbA1c testing devices.

• Growing awareness about glycemic control

There is increasing awareness among individuals and healthcare providers about the importance of glycemic control in managing diabetes. HbA1c tests provide a reliable measure of long-term blood glucose levels, driving the demand for HbA1c testing.

• Technological advancements in HbA1c testing devices

Technological advancements have led to the development of innovative and accurate HbA1c testing devices. These technological advancements have improved the accuracy, speed, and convenience of HbA1c testing, contributing to market growth.

Opportunities

• Growing diabetic population in emerging economies

Emerging economies, such as India, China, and Brazil, are witnessing a significant increase in the diabetic population. This presents opportunities for market players to expand their presence and tap into these growing markets.

• Development of advanced HbA1c testing methods

A continuous focus is on developing advanced HbA1c testing methods, including point-of-care devices, lab-on-a-chip technologies, and non-invasive testing approaches. These developments present opportunities for innovation and market growth.

Challenges/ Restraints

• High cost of HbA1c testing devices:

The cost of HbA1c testing devices can be a significant restraint, especially in developing countries with limited healthcare budgets. The high cost of these devices may hinder their adoption and limit market growth.

• Lack of reimbursement policies

In some regions, there may be limited or no reimbursement coverage for HbA1c testing, which can pose a challenge for patients and healthcare providers. The absence of reimbursement policies may impact the demand for HbA1c testing devices. A lack of awareness and understanding about HbA1c Testing among the general population can hinder market growth. Many individuals may not fully comprehend the benefits and coverage provided by such policies, leading to lower demand and adoption.

• Interference from hemoglobin variants

Certain hemoglobin variants and conditions, such as anemia, can interfere with the accuracy of HbA1c test results. Overcoming these challenges and ensuring accurate and reliable results is a key challenge for HbA1c testing manufacturers

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the HbA1c Testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In July 2020, Liberty General Insurance launched ‘Critical Connect’, where one can choose from two programs for a sum insured ranging from Rs 1 lakh up to Rs. 1 crore. If the customer opts for plan A, they can choose Critical Illness Bundles Covering 9, 25, or 43 critical illnesses. Plan B offers disease-specific bundles such as Heart Protect, Cancer Protect, Renoliv Protect, and Brain Protect. With this launch, the company has enhanced its offering to the customers for HbA1c testing
• In November 2022, Nassau Financial Group announced that it entered into a binding agreement with Delaware Life Insurance Company to buy the Delaware Life Insurance Company of New York.

Global HbA1c Testing Market Scope

The market is segmented on the basis of product type, technology, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Product Type

• Instruments 
• Reagents
• Kits

Technology

• Ion-exchange HPLC
• Enzymatic assay
• Affinity binding chromatography
• Turbidimetric inhibition immunoassay
•  Others

End User

• Hospitals and clinics,
• Diagnostic laboratories
• Homecare
•  research institution
•  others.

HbA1c Testing Market Regional Analysis/Insights

The market is analysed, and market size insights and trends are provided by country, power source, product, and application, as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia- Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, rest of Middle East & Africa.

North America region leads the market owing to the rise in activities such as research, awareness campaigns, and increased joint ventures by public and private organizations in the U.S. and Canada.

Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2023 to 2030 because of the rapid development in the healthcare infrastructure and increase in the per capita disposable incomes.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

HbA1c Testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for HbA1c Testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the HbA1c Testing market. The data is available for historic period 2010-2020.

Competitive Landscape and HbA1c Testing Market Share Analysis

The HbA1c Testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to HbA1c Testing market.

Some of the major players operating in the HbA1c Testing market are:

• Abbott - U.S.
• Bio-Rad Laboratories, Inc. - U.S.
• ARKRAY, Inc. - Japan
• Danaher - U.S.
• F. Hoffmann-La Roche Ltd. - Switzerland
• Siemens Healthcare GmbH - Germany
• TransAsia Bio-Medicals - India
• Trinity Biotech Ireland - Ireland
• EKF Diagnostics - U.K.
• Randox Laboratories Ltd. – U.K.
• HemoCue India - India
• Eurolyser Diagnostica GmbH - Austria
• Sekisui Diagnostics - U.S.
• Healio - U.S.
• Diazyme Laboratories, Inc. - U.S.
• Beckman Coulter, Inc. - U.S.
• A. Menarini Diagnostics srl - Italy
• SEBIA - France
• PTS Diagnostics - U.S.
• DiaSys Diagnostic Systems GmbH - Germany

SKU-43667